The fresh funding for Wellster comes from investors Claret Capital and Mangrove Capital. With this investment, the Wellster Healthtech Group claims to be the best-funded integrated healthcare platform in Europe. first part of the financing round in June Dermapharm and HV Capital, among others, have invested.
Wellster combines digital telemedicine offerings, each focused on a specific health topic, into portals. The Munich-based company currently covers mental health, intimate health, hair and skin health, and medical self-tests. The startup has been online with its portals since May 2019 and currently serves 1.5 million patients.
With the fresh capital, Wellster plans to build a platform for women's health, offering intimate health treatments and medical lifestyle products. The company already operates the Spring portal as a male counterpart.
Wellster has a “strong team that aims to disrupt the huge European market”
“The funding comes at a key moment in our development,”
so Manuel Nothelfer, co-founder of Wellster Healthtech Group.
“It reinforces our goal of maintaining our leadership position in the European market and expanding our offerings for personalized healthcare services.”
Co-founder Nico Hribernik says:
“Our strong customer base, European roots, and experience with European regulations give us a significant advantage over American companies seeking to enter the market.”
The potential of the healthcare market is the “non-plus-ultra” in terms of its size, says Hans-Juergen Schmitz, Managing Partner at Mangrove Capital Partners:
"What makes Wellster particularly attractive is the combination of an appealing offering aimed directly at patients and a strong team committed to disrupting the vast European market. Both fit perfectly with our investment strategy."
